Soleno Therapeutics Overview
Soleno Therapeutics Target Price
Soleno Therapeutics target price — quarterly history, peer benchmarks, and growth trends.
Get informed when a big investor buys or sells
+ FollowShare Price
$53.01
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-17 | Wells Fargo | $53 |  0% upside |  |
| 2026-03-04 | H.C. WainwrightRaghuram Selvaraju | $100 | 88.6% upside | |
| 2026-01-20 | Wells FargoDerek Archila | $114 | 115.1% upside | |
| 2026-01-20 | H.C. Wainwright | $120 | 126.4% upside | |
| 2026-01-13 | Robert W. Baird | $107 | 101.8% upside | |
| 2026-01-12 | Wolfe Research | $60 | 13.2% upside | |
| 2025-11-05 | Wells FargoDerek Archila | $106 | 100% upside | |
| 2025-10-07 | Goldman Sachs | $125 | 135.8% upside | |
| 2025-07-11 | Robert W. BairdBrian Skorney | $121 | 128.3% upside | |
| 2025-03-28 | GuggenheimDebjit Chattopadhyay | $81 | 52.8% upside | |
| 2025-03-27 | Robert W. Baird | $102 | 92.4% upside | |
| 2025-03-27 | UBS | $105 | 98.1% upside | |
| 2024-12-02 | H.C. WainwrightRaghuram Selvaraju | $70 | 32.1% upside | |
| 2024-10-01 | Stifel NicolausDae Gon Ha | $74 | 39.6% upside | |
| 2024-08-27 | Stifel NicolausDae Gon | $59 | 11.3% upside | |
| 2024-08-27 | OppenheimerLeland Gershell | $65 | 22.6% upside | |
| 2024-05-23 | Piper SandlerYasmeen Rahimi | $93 | 75.4% upside | |
| 2024-05-09 | Robert W. BairdBrian Skorney | $72 | 35.8% upside | |